Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Isis Pharmaceuticals, Inc. (NQ: ISIS)
20.66 USD  +0.50 (+2.48%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Isis Pharmaceuticals, Inc.
 
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Drug stocks slide with broader market
May 20, 2010
Drug stocks skidded into negative territory Thursday as the broader market drove south, fueled escalating fears about the deepening sovereign debt crisis in Europe. Read More
category Biotechnology , GILD , BAYRY , and 16 more.
from MarketWatch
Needham & Company Reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Pipelines to Address Cancer Through Antisense Technology
May 20, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5657851 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 05/06: Kraft Foods (KFT), DirecTV (DTV), MGM Mirage (MGM), Crocs (CROX), Xenoport (XNPT) Report
May 05, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5599495 for the full story. Read More
from StreetInsider.com News Articles
Regulus Therapeutics Presents Data from Therapeutic Oligonucleotides targeting microRNA
April 15, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5532129 for the full story. Read More
from StreetInsider.com News Articles
Needham & Company reiterates a 'Buy' on ISIS Pharmaceuticals (ISIS); Cardiovascular Program Update – Multiple Well-Characterized Drug Candidates
April 15, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5531836 for the full story. Read More
from StreetInsider.com News Articles
RXi Marches Ahead on RNA Development
April 12, 2010
If you’re keeping an eye on the gene silencing space you probably heard that RXi Pharmaceuticals (RXII) inked deals with two private companies on Monday that open up research and development... Read More
from Minyanville Headlines
BioMed Realty Trust (BMR) Expands Real Estate Partnership with Isis Pharma (ISIS)
April 05, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5501180 for the full story. Read More
from StreetInsider.com News Articles
RNA: The New Building Blocks Of Biotech Investing
March 31, 2010
RNA DNA’s less-talked-about counterpart has been all the rage in biotechs over the last few years. If you aren’t following these companies you're missing out on a wealth of opportunity.RNA acts like... Read More
from Minyanville Headlines
GlaxoSmithKline, Sanofi-Aventis: Rx for When Drug Patents Expire
March 31, 2010
GSK has made a new alliance to support its new strategy of targeting rare, serious diseases, while Sanofi-Aventis is revamping its plants for a fresh focus. Both are facing a revenue falloff when their... Read More
category glaxosmithkline , sny , arql , and 9 more.
from DailyFinance.com
Isis Pharmaceuticals (ISIS) NewsBite - ISIS Rises on GlaxoSmithKline (GSK) Deal
March 31, 2010
Isis Pharmaceuticals (NASDAQ: ISIS) opened at $10.94. So far today, the stock has hit a low of $10.85 and a high of $11.43. ISIS is now trading at $11.29, up $0.99 (9.61%). Over the last 52 weeks the... Read More
category ISIS,GSK
from MarketIntelligenceCenter.com
ArQule, Isis shrug off sector's weaker trend
March 31, 2010
Shares of ArQule double in value as a Phase II clinical trial has shown the company’s ARQ 197 compound effective in helping slow the progression of lung cancer. Also trading higher are shares of Isis... Read More
category Biotechnology , OSIP , $DRG , and 6 more.
from MarketWatch
Wednesday's biggest gaining and declining stocks
March 31, 2010
Stocks expected to move significantly in Wednesday's trading include Ameron, Apple, Jos. A. Bank, CKE Restaurants, Dollar General, H.B. Fuller, Honeywell, Isis Pharmaceuticals, Research In Motion, SAIC... Read More
category RIMM , CATM , ONP , and 23 more.
from MarketWatch
Stocks in the News: Honeywell, Rite Aid, SAIC
March 31, 2010
The following is a round-up of news likely to affect stock prices today: Peabody Energy Corp. ( BTU ) made a $3 billion takeover bid for Australia's Macarthur Coal Ltd., but the Australian company said... Read More
category aapl, rimm, tot, rds/b, zz, twgp, goog, josb, sny, gsk, isis, mu, rad, f, dg, hon, sai , isis , rad , and 15 more.
from DailyFinance.com
Isis Pharmaceuticals (ISIS) Enters Collaboration with GSK on RNA Therapeutics Worth $35M Upfront
March 31, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5483311 for the full story. Read More
from StreetInsider.com News Articles
Genzyme (GENZ) and Isis Pharma (ISIS) Mipomersen Phase 3 Meets Primary Endpoint
March 15, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5437261 for the full story. Read More
from StreetInsider.com News Articles
'Takeover Fever' Continues In Biotech After Facet (FACT) Takeover, Who's Next?
March 10, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5425314 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharma (ISIS) Earns $6M Milestone Payment from Bristol-Myers Squib (BMY)
March 08, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5416180 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharma (ISIS) Initiates ISIS-SOD1Rx Phase I in Patients with ALS
March 05, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5412521 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals Posts Larger 4Q Loss
March 01, 2010
Revenue rose 8.8% to $32.3 million, yet revenue from research and development dropped 25%. Read More
category Health Care
from FOXBusiness.com
ISIS Pharm (ISIS) Posts Q4 Loss of $0.16, Wider than Expectations
March 01, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5391668 for the full story. Read More
from StreetInsider.com News Articles
Trading Radar for 03/01: DISH Network (DISH), Oveseas Shipholding (OSG), Sotheby's (BID), Nutrisystem (NTRI) Report
February 26, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5389295 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals (ISIS) Fourth Quarter Earnings Preview
February 26, 2010
Isis Pharmaceuticals (NASDAQ: ISIS) opened at $8.96. So far today, the stock has hit a low of $8.76 and a high of $8.97. ISIS is now trading at $8.80, down $0.12 ...(Click the story link or go to... Read More
category ISIS
from MarketIntelligenceCenter.com
Drug stocks in retreat; Alexza rebounds
February 11, 2010
Drug stocks fall while shares of Alexza Pharmaceuticals were showing signs of rebounding after tumbling 10% in Wednesday's session. Read More
category Market News , Biotechnology , GENZ , and 9 more.
from MarketWatch
Analysts Thoughts On Isis Pharmaceuticals (ISIS) After 19% Sell-Off
February 11, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5332445 for the full story. Read More
from StreetInsider.com News Articles
Study Goals Met For Genzyme And Isis
February 10, 2010
Genzyme Corp. (Nasdaq: GENZ) and Isis Pharmaceuticals Inc. (Nasdaq: ISIS) reported that a phase 3 clinical trial of their cholesterol treatment mipomersen met study goals but the stock prices fell.... Read More
from MarketMinute.com Stock News
Isis Pharmaceuticals (ISIS) NewsBite - ISIS Falls on Concerns Over Cholesterol Drug
February 10, 2010
Isis Pharmaceuticals (NASDAQ: ISIS) opened at $9.08. So far today, the stock has hit a low of $8.85 and a high of $9.34. ISIS is now trading at $9.15, down $1.89 (-17.12%). Over the last 52 weeks the... Read More
category ISIS,GENZ
from MarketIntelligenceCenter.com
Isis, Alexza in spotlight
February 10, 2010
Drug stocks dip in early trading, with shares of Isis Pharmaceuticals plunging almost 20% after it releases mixed Phase III clinical data for its cholesterol drug mipomersen. Read More
category Market News , Biotechnology , GENZ , and 8 more.
from MarketWatch
Morning Movers 2/10: ATHX, CYBI, LIOX, OPEN, NTGR Higher; ISIS, DF, RTK Lower
February 10, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5327665 for the full story. Read More
from StreetInsider.com News Articles
Isis Pharmaceuticals (ISIS) Falls On Safety Concerns
February 10, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5327051 for the full story. Read More
from StreetInsider.com News Articles
Trade Deficit Leaps, Markets Open Lower
February 10, 2010
The nation's trade deficit leaped by a larger than expected $40.18 billion in December to weigh down the markets to a lower open with the Dow falling 89 points to 9969. Nasdaq lost 18 points to 2131. Read More
category Market News
from MarketMinute.com Market Updates
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here